JP2024518429A5 - - Google Patents

Info

Publication number
JP2024518429A5
JP2024518429A5 JP2023568486A JP2023568486A JP2024518429A5 JP 2024518429 A5 JP2024518429 A5 JP 2024518429A5 JP 2023568486 A JP2023568486 A JP 2023568486A JP 2023568486 A JP2023568486 A JP 2023568486A JP 2024518429 A5 JP2024518429 A5 JP 2024518429A5
Authority
JP
Japan
Prior art keywords
cancer
compound
solvent
diffraction pattern
radiation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023568486A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024518429A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/028606 external-priority patent/WO2022240886A1/en
Publication of JP2024518429A publication Critical patent/JP2024518429A/ja
Publication of JP2024518429A5 publication Critical patent/JP2024518429A5/ja
Pending legal-status Critical Current

Links

JP2023568486A 2021-05-11 2022-05-10 4-[5-[(3s)-3-アミノピロリジン-1-カルボニル]-2-[2-フルオロ-4-(2-ヒドロキシ-2-エチルプロピル)フェニル]フェニル]-2-フルオロ-ベンゾニトリルの塩の固体形態 Pending JP2024518429A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163187125P 2021-05-11 2021-05-11
US63/187,125 2021-05-11
PCT/US2022/028606 WO2022240886A1 (en) 2021-05-11 2022-05-10 Solid forms of salts of 4-[5-[(3s)-3-aminopyrrolidine-1-carbonyl]-2-[2-fluoro-4-(2-hydroxy-2-ethylpropyl)phenyl]phenyl]-2-fluoro-benzonitrile

Publications (2)

Publication Number Publication Date
JP2024518429A JP2024518429A (ja) 2024-05-01
JP2024518429A5 true JP2024518429A5 (cg-RX-API-DMAC7.html) 2025-05-20

Family

ID=81854861

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023568486A Pending JP2024518429A (ja) 2021-05-11 2022-05-10 4-[5-[(3s)-3-アミノピロリジン-1-カルボニル]-2-[2-フルオロ-4-(2-ヒドロキシ-2-エチルプロピル)フェニル]フェニル]-2-フルオロ-ベンゾニトリルの塩の固体形態

Country Status (6)

Country Link
US (1) US20240228438A1 (cg-RX-API-DMAC7.html)
EP (1) EP4337638A1 (cg-RX-API-DMAC7.html)
JP (1) JP2024518429A (cg-RX-API-DMAC7.html)
CN (1) CN117769540A (cg-RX-API-DMAC7.html)
TW (1) TW202308991A (cg-RX-API-DMAC7.html)
WO (1) WO2022240886A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20250295660A1 (en) 2022-05-09 2025-09-25 Oryzon Genomics, S.A. Methods of treating nf1-mutant tumors using lsd1 inhibitors
US20250275969A1 (en) 2022-05-09 2025-09-04 Oryzon Genomics, S.A. Methods of treating malignant peripheral nerve sheath tumor (mpnst) using lsd1 inhibitors
US20260151399A1 (en) 2022-11-24 2026-06-04 Oryzon Genomics, S.A. Combinations of lsd1 inhibitors and menin inhibitors for treating cancer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2812598A1 (en) * 2010-11-10 2012-05-18 Theravance, Inc. Crystalline forms of an alkoxyimidazol-1-ylmethyl biphenyl carboxylic acid
BR112017026173A2 (pt) * 2015-07-07 2018-08-14 Japan Tobacco, Inc. Método para produção de derivado de 7h-pirrolo [2,3-d]pirimidina e intermediário do mesmo
FI3381896T3 (fi) * 2015-11-27 2023-04-21 Taiho Pharmaceutical Co Ltd Bifenyyliyhdiste tai sen suola
NZ754797A (en) * 2016-12-28 2022-05-27 Tonix Pharma Holdings Ltd Tianeptine oxalate salts and polymorphs
MX2022005811A (es) * 2019-11-13 2022-06-08 Taiho Pharmaceutical Co Ltd Sal novedosa de compuesto de terfenilo.

Similar Documents

Publication Publication Date Title
JP2023554492A5 (cg-RX-API-DMAC7.html)
WO2022258040A1 (zh) 用于tead抑制剂的杂环化合物
AU2006323025B2 (en) Polymorphs of a c-Met/HGFR inhibitor
JP2022507251A5 (cg-RX-API-DMAC7.html)
WO2001047891A1 (en) Heterocyclic compounds having sulfonamide groups
WO2016011979A1 (zh) 2,4-二取代7H-吡咯并[2,3-d]嘧啶衍生物、其制法与医药上的用途
US11155537B2 (en) Crystal of benzofuran derivative free base and preparation method
JP2022523368A5 (cg-RX-API-DMAC7.html)
JP2024526882A5 (cg-RX-API-DMAC7.html)
WO2016124067A1 (zh) 一种周期素依赖性蛋白激酶抑制剂的羟乙基磺酸盐、其结晶形式及制备方法
JP2022534788A5 (cg-RX-API-DMAC7.html)
DK150483B (da) Analogifremgangsmaade til fremstilling af trans-3-(4-oxo-4h-quinazolin-3-yl)-2-propensyrederivater eller salte deraf med farmaceutisk acceptablesyrer
CN110862389A (zh) 一种阿哌沙班晶型的制备方法
KR100467668B1 (ko) 1,2,4-트리아졸 유도체, 그 제조방법 및 약제학적 조성물
JP2022535850A5 (cg-RX-API-DMAC7.html)
TW202308991A (zh) 三苯化合物之固體形式
JP2022540678A5 (cg-RX-API-DMAC7.html)
WO2000050408A1 (en) Pyridazin-3-one derivatives and medicines containing the same
US20110021582A1 (en) Benzophenone thiazole derivatives useful for inhibiting formation of microtubule and method for producing the same
WO2002006249A1 (en) Method for producing 1-substituted-1,2,3-triazole derivative
WO2020156162A1 (zh) Mek抑制剂及其在医药上的应用
JP2020083892A5 (cg-RX-API-DMAC7.html)
KR100470075B1 (ko) 1,2,4-트리아졸 유도체, 그 제조방법 및 약제학적 조성물
CN107226807B (zh) 端锚聚合酶抑制剂
JP2024529533A5 (cg-RX-API-DMAC7.html)